← Open Payments lookup

ANNA REYES-CRAWHORN: Open Payments

NPI 1154978732 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$929 in 40 payments from 14 companies in 2025. Trend: 2023 $364 · 2024 $421 · 2025 $929

Food & beverage: $830Education: $99
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$210
Teva Pharmaceuticals USA, Inc.4$168
Vanda Pharmaceuticals Inc.5$119
ABBVIE INC.4$85
Otsuka America Pharmaceutical, Inc.3$72
Supernus Pharmaceuticals, Inc.3$53
Alkermes, Inc.2$52
Neurocrine BioSciences, Inc.2$44
Almatica Pharma LLC1$26
Lundbeck LLC1$26

Products named: CAPLYTA, VRAYLAR, REXULTI, FANAPT, HETLIOZ, Qelbree, ARISTADA, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.